In this Coffee and Conversation, Elizabeth Jennings shares how 2020 has reshaped thinking around early stage investing--and how innovative businesses can use this to their advantage. Especially pertinent to healthcare and cleantech, we walk through techniques for developing a resilient commercial narrative and strategy to move forward conversations with both investors and partners alike amid the relative uncertainty of 2021. Learn how to reframe your go-to-market strategy to align with fund theses and strategies, tactics for getting useful feedback from key players, and early steps you can take to improve your leverage.
